Drug Side Effects
Search
MESENTERIC FIBROSIS
MESENTERIC FIBROSIS
was reported 22 times
MESENTERIC FIBROSIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Antimetabolite Immunosuppressant [EPC]
1
0.0000
1
Vascular Endothelial Growth Factor Inhibitor [EPC]
4
0.0000
2
Epidermal Growth Factor Receptor Antagonist [EPC]
1
0.0000
3
Peroxisome Proliferator Receptor alpha Agonist [EPC]
1
0.0000
4
Angiotensin Converting Enzyme Inhibitor [EPC]
2
0.0000
5
Platinum-based Drug [EPC]
4
0.0000
6
Topoisomerase Inhibitor [EPC]
1
0.0000
7
Nucleoside Analog Antiviral [EPC]
1
0.0000
8
Programmed Death Receptor-1 Blocking Antibody [EPC]
1
0.0000
9
Sulfonylurea [EPC]
1
0.0000
10
Calcineurin Inhibitor Immunosuppressant [EPC]
1
0.0000
11
Nucleoside Metabolic Inhibitor [EPC]
2
0.0000
12
Janus Kinase Inhibitor [EPC]
1
0.0000
13
Loop Diuretic [EPC]
2
0.0000
14
Alkylating Drug [EPC]
1
0.0000
15
Tumor Necrosis Factor Blocker [EPC]
4
0.0000
16
Progestin [EPC]
1
0.0000
17
Proton Pump Inhibitor [EPC]
2
0.0000
18
Vitamin D [EPC]
1
0.0000
19
Vitamin B12 [EPC]
1
0.0000
20
Dihydropyridine Calcium Channel Blocker [EPC]
1
0.0000
21
Vitamin C [EPC]
1
0.0000
22
Folate Analog Metabolic Inhibitor [EPC]
1
0.0000
23
Kinase Inhibitor [EPC]
1
0.0000
24
Corticosteroid [EPC]
1
0.0000
25
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000